Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 20/06/2018
Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Buy | Transaction Date : 21/06/2018
Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 22/06/2018
Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 25/06/2018
Of Details DOD BIOTECH PUBLIC COMPANY LIMITED 2021 Company Year 31/12/2021 DOD BIOTECH PUBLIC COMPANY LIMITED 2021 Consolidated Year 31/12/2021 DOD BIOTECH PUBLIC COMPANY LIMITED 2021 Reviewed
, held a joint meeting to discuss and exchange views on strategies for promoting, developing, and supervising digital assets, including the involvement of the government, the Thai Digital Asset
The Securities and Exchange Commission (SEC) participated in the Declaration of Intent to drive and promote the involvement of the business sector in the Thai capital market in preserving and
concerning the amendments to the IPO approval regulations in the part of the issuer’s qualification of non-involvement in any illegal business. The essences of the amendments are as follows: (1) Revising
from insufficient involvement of engagement partners and engagement quality control reviewers (EQCRs) and incomplete audit manuals as required by quality control standard. Findings by respective average
compromise business opportunities.The SEC is therefore proposing to amend the IPO regulations by clarifying the issuer’s qualification of non-involvement in an illegal business to ensure clarity and